David Linetsky Sells 11,616 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,616 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $29.70, for a total transaction of $344,995.20. Following the sale, the senior vice president now owns 218,135 shares in the company, valued at $6,478,609.50. The trade was a 5.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

David Linetsky also recently made the following trade(s):

• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The stock was sold at an average price of $29.52, for a total transaction of $8,856.00.
• On Wednesday, February 5th, David Linetsky sold 720 shares of Phreesia stock. The stock was sold at an average price of $29.50, for a total transaction of $21,240.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The stock was sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total value of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The shares were sold at an average price of $24.88, for a total transaction of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The shares were sold at an average price of $24.85, for a total transaction of $294,547.05.

Phreesia Trading Up 0.5 %

Phreesia stock traded up $0.15 during midday trading on Tuesday, reaching $29.99. The stock had a trading volume of 409,526 shares, compared to its average volume of 382,504. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The stock has a market capitalization of $1.74 billion, a PE ratio of -20.40 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The stock’s 50-day simple moving average is $26.93 and its 200 day simple moving average is $23.68.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter last year, the firm earned ($0.58) earnings per share. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. Analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Johnson Financial Group Inc. boosted its holdings in Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares during the last quarter. R Squared Ltd purchased a new position in Phreesia in the fourth quarter valued at about $30,000. International Assets Investment Management LLC raised its position in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares during the period. BankPlus Trust Department purchased a new position in Phreesia in the fourth quarter valued at about $34,000. Finally, Quarry LP raised its position in Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after purchasing an additional 1,923 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

PHR has been the topic of a number of recent research reports. Robert W. Baird reduced their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Piper Sandler reiterated an “overweight” rating and set a $33.00 target price (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Truist Financial increased their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Friday, January 10th. Thirteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.